GSA Capital Partners’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619K | Sell |
55,059
-73,514
| -57% | -$826K | 0.04% | 767 |
|
|
2025
Q1 | $733K | Buy |
+128,573
| New | +$733K | 0.07% | 535 |
|
|
2024
Q4 | – | Sell |
-120,169
| Closed | -$979K | – | 1694 |
|
|
2024
Q3 | $979K | Buy |
120,169
+50,282
| +72% | +$410K | 0.07% | 480 |
|
|
2024
Q2 | $935K | Buy |
+69,887
| New | +$935K | 0.07% | 549 |
|
|
2023
Q4 | – | Sell |
-1,899
| Closed | -$138K | – | 1582 |
|
|
2023
Q3 | $138K | Buy |
+1,899
| New | +$138K | 0.01% | 1355 |
|
|
2023
Q2 | – | Sell |
-1,815
| Closed | -$97K | – | 1600 |
|
|
2023
Q1 | $97K | Sell |
1,815
-1,136
| -38% | -$60.7K | 0.01% | 1364 |
|
|
2022
Q4 | $199K | Buy |
2,951
+302
| +11% | +$20.4K | 0.02% | 1190 |
|
|
2022
Q3 | $331K | Sell |
2,649
-3,447
| -57% | -$431K | 0.04% | 860 |
|
|
2022
Q2 | $580K | Buy |
+6,096
| New | +$580K | 0.09% | 408 |
|
|
2022
Q1 | – | Sell |
-661
| Closed | -$220K | – | 1500 |
|
|
2021
Q4 | $220K | Buy |
+661
| New | +$220K | 0.03% | 1150 |
|